Respiratory

Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.

Cedar pollen allergen-specific IgE values may be sufficient for diagnostic use in pollen allergy screening.

Data suggest a high rate of secondary bacterial ventilator-associated pneumonia in patients with COVID-19 and acute respiratory distress syndrome.

The FDA granted the EUA based on the phase 3 trial results that demonstrated vilobelimab's efficacy compared to placebo, with a 23.9% relative reduction in all-cause mortality from COVID-19 at 28 days.

The effects of complex interactions with pollens, meteorological variables, and air pollutants on the concentration of pollen in a changing climate is still not well understood.

The drug, called Atovaquone, has been voluntarily recalled due to possible Bacillus cereus contamination.

Masking, social distancing, and school closures all contributed to children being exposed to fewer environmental triggers of asthma.

The British pharma giant has teamed up with Johnson for a promotional campaign as they approach the finish line of an RSV vaccine.

A strong association between air pollution exposure and bone mineral loss in postmenopausal women was identified by investigators.

Researchers estimate the protection from COVID-19 reinfection based on the variant and time since a patient's previous infection.

The use of biomarker profiles to guide asthma treatment decisions have not been well-studied.

A lower level of education was associated with an increased risk for uncontrolled asthma, particularly in adults with non-atopic asthma and those who used inhaled corticosteroids daily.

RSV cases spiked to unprecedented levels this season. Why were these infections so frequent and severe, and why has vaccine development taken so long?

Patients with good continuous positive airway pressure (CPAP) compliance saw improvements in lung function after 12 months, compared to patients with poor CPAP compliance.

Investigators analyzed the proportion of individuals with 1 of 3 clusters of Long COVID symptoms.

A follow-up of a trial cohort showed that children aged 5 years born to pregnant smokers had improved airway function when vitamin C supplementation was administered during pregnancy compared to placebo.

The medication showed significant efficacy for treating patients with moderate to severe COPD exacerbations.

The FDA has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.

Moderna’s mRNA-1345 vaccine targets RSV in older adults.

Airsupra has been approved for as-needed use to reduce the risk of asthma exacerbations

With the respiratory season in full swing and COVID-19 continuing to infect, knowing the basics of the common cold, influenza, COVID-19, and respiratory syncytial virus can help ensure patients get the right care.

The US Food Administration has agreed to review an application for nirsevimab (Beyfortus; AstraZeneca and Sanofi) to protect infants against RSV.

Take a look back at our most popular respiratory coverage for 2022.

Study participants experienced better outcomes vs standard of care with a digital inhaler system.

Findings from research presented at the American College of Chest Physicians suggest the importance of selecting the right biologic from the start.

Besides providing education and counseling, pharmacists play a key role in the administration of vaccines.

Early interventions might preserve lung function, particularly in younger patients with frequent asthma exacerbations, say authors.

Secretions of fibroblast growth factor and granulocytic colony-stimulating growth factor in airway epithelium may be to blame.

The Patient-Centered Outcomes Research Institute (PCORI) has approved an award for the American Academy of Family Physicians (AAFP) of $31 million to fund a large comparative study of asthma treatments.